# Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

> **NCT00006656** · PHASE2 · UNKNOWN · sponsor: **Direct Therapeutics**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** carmustine in ethanol
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00006656
- **Lead sponsor:** Direct Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006656, "Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00006656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*